InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,234.00
(
0.21%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.41
(
-1.35%
)
Bitcoin
69,589.42
(
-2.60%
)
Post# of 66
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Shizane

Send PM Follow Ignore
Followers 1
Posts 87
Boards Moderated 1
Alias Born 08/14/2013

Shizane

Re: None

Monday, 08/26/2013 9:20:41 AM

Monday, August 26, 2013 9:20:41 AM

Post# of 66
NEWS: CXM, NVO, FCSC

CXM

Cardium's LifeAgain Announces Commercialization Agreement With AgencyONE Based On Advanced Medical Data Analytics Platform Technology

NVO

On 8 August 2013, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14.0 billion to be executed during a 12-month period beginning 31 January 2013.

Company Announcement No 57 2013: http://hugin.info/2013/R/1724840/575019.pdf

FCSC

Fibrocell Science Appoints Greg Weaver Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary

SHIZANE





*Above statements are wholly my opinion (unless stated otherwise) and should be a taken as such

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up